<DOC>
	<DOC>NCT01862861</DOC>
	<brief_summary>Bioidentical Hormone Replacement Therapy (BHRT) to assess a change in the number of various menopausal symptoms such as hot flashes and night sweats in surgically or naturally induced peri or post-menopausal women.</brief_summary>
	<brief_title>Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study</brief_title>
	<detailed_description>Participants will be receiving a customized bioidentical hormone regimen which may include a combination of estrogens, progesterone, and testosterone.</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>Participants must be women who are in surgically or naturally induced menopause or perimenopause, as determined by their physician. Participants must be starting a new regimen of bioidentical hormone replacement therapy. Participants must be expected to receive therapy for at least 12 weeks. Participants must be between 30 and 65 years of age. Participants must be able to provide sound written informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf. Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription. Participants must not be pregnant or breastfeeding women. Participants must not be managed outside the Medimix Specialty Pharmacy system with regard to their bioidentical hormone replacement therapy. Participants must not be using another bioidentical hormone at the time of enrollment.</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Bioidentical Hormone Replacement Therapy</keyword>
</DOC>